MARKET

NWBO

NWBO

Northwest Bio
OTCMQB
0.231
+0.003
+1.09%
Closed 15:58 12/04 EST
OPEN
0.230
PREV CLOSE
0.229
HIGH
0.235
LOW
0.228
VOLUME
1.17M
TURNOVER
270.81K
52 WEEK HIGH
0.477
52 WEEK LOW
0.169
MARKET CAP
353.13M
P/E (TTM)
-3.5267
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NWBO last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at NWBO last week (1117-1121)?
Weekly Report · 11/24 09:46
Northwest Biotherapeutics Secures $5M Convertible Note Financing
TipRanks · 11/20 21:49
Northwest Biotherapeutics Secures $5 Million Convertible Loan from Yorkville Advisors
Reuters · 11/20 21:26
Northwest Biotherapeutics Begins Construction of Grade C Manufacturing Suite in UK Facility
Reuters · 11/20 19:41
Northwest Biotherapeutics Inc. Announces Date for Upcoming Annual Stockholders Meeting
Reuters · 11/19 21:17
Weekly Report: what happened at NWBO last week (1110-1114)?
Weekly Report · 11/17 09:46
Weekly Report: what happened at NWBO last week (1103-1107)?
Weekly Report · 11/10 09:45
More
About NWBO
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its platform technology, DCVax, is a personalized immune therapy that uses a patient’s own dendritic cells, or DCs, the master cells of the immune system, as the therapeutic agent. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, and others.

Webull offers Northwest Biotherapeutics Inc stock information, including OTCMQB: NWBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NWBO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NWBO stock methods without spending real money on the virtual paper trading platform.